Global Spectral Computed Tomography (CT) Market Size By Product (Spiral CT, Electron Beam Tomography, Multi-Slice Computed Tomography), By Application (Pharmaceutical Industries, Hospitals, Research and Development), By Geographic Scope And Forecast

Spectral Computed Tomography (CT) Market Size And Forecast

Spectral Computed Tomography (CT) Market size was valued at USD 7.37 Billion in 2024 and is projected to reach USD 8.18 Billion by 2031 , growing at a CAGR of 1.31% from 2024 to 2031. The Global Spectral Computed Tomography (CT) Market has witnessed strong growth owing to the rising prevalence of diseases such as cancer, neurological disorders, and cardiac diseases across the globe, increasing expenditure on the healthcare IT sector, and technological advancements in the diagnostics sector. The Global Spectral Computed Tomography (CT) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Spectral Computed Tomography (CT) Market Definition

Spectral computed tomography (CT) is also known as dual-energy CT (DECT) is an exceptional form of computed tomography extensively used in x-ray scanning techniques. It separates the energy into two or more narrow energy bands rather than using one broad energy band of x-rays. Energy bands are received differently by diverse body tissues.

The introduction of spectral computed tomography has transformed the diagnostic system by giving radiologists a more transparent view of any type of discrepancy in body organs. Spectral computed tomography can produce image acquisition and processing at multiplied energy levels, which are to developing visualization than conventional CT and providing primary diagnosis for disorders having large prevalence these days such as aneurysm, cancer, tumor, cardiovascular impairment, and disease correlated to bones.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Spectral Computed Tomography (CT) Market Overview

The Global Spectral Computed Tomography (CT) Market is principally driven by increasing technological advancements in diagnostic imaging devices. Computed tomography, radiography, and fluoroscopy are diverse forms of medical imaging devices used in x-ray scanning by hospitals. The increasing adaption of IT in medical devices to improve the quality of the product is a notable step in the medical imaging industry.

Medical image management is intimately associated with diagnosis services and is a crucial component of the healthcare IT sector. Besides, easy availability of conventional x-ray imaging systems and their price the spectral tomography is augmenting popularity, and as a result adoption is anticipated to increase shortly. Moreover, diseases with a high prevalence rate, particularly chronic non-communicable diseases are supposed to spurt the Spectral Computed Tomography (CT) Market.

However, a huge cost for imaging, contrasting agent reaction, high installation cost, lack of skilled personnel, the initial phase of technology, lack of awareness and are expected to counter the market growth during the forecast period. Nevertheless, the rising technological advancements in diagnostic imaging devices are expected to offer lucrative growth opportunities for the market during the forecast period.

Global Spectral Computed Tomography (CT) Market Segmentation Analysis

The Global Spectral Computed Tomography (CT) Market is segmented on the basis of Product, Application, And Geography.

Spectral Computed Tomography (CT) Market, By Product

• Spiral CT
• Electron Beam Tomography
• Multi-Slice Computed Tomography
• Positron Emission Tomography (Pet)
• Single-Photon Emission Computed Tomography

Based on Product, the market is bifurcated into Spiral CT, Electron Beam Tomography, Multi-Slice Computed Tomography, Positron Emission Tomography (Pet), and Single-Photon Emission Computed Tomography. The Electron Beam Tomography segment is estimated to witness the highest CAGR for the forecast period. Electron beam computed tomography (EBCT) is a comparatively modern technology that has been used principally to detect coronary artery calcification in adult patients.

Spectral Computed Tomography (CT) Market, By Application

• Pharmaceutical Industries
• Hospitals
• Research and Development
• Medical Research Laboratories
• Academic Medical Institutes and Universities

Based on Application, the market is bifurcated into Pharmaceutical Industries, Hospitals, Research and Development, Medical Research Laboratories, and Academic Medical Institutes and Universities. The Hospitals segment is estimated to witness the highest CAGR for the forecast period. The growth of the segment is attributed to rising in the number of emergency admissions in hospitals and surgeries. Computed tomography is an important tool for the diagnosis of pre-operative and post-operative to recognize the effectiveness of the treatment.

Spectral Computed Tomography (CT) Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world.

Based on Regional Analysis, The Global Spectral Computed Tomography (CT) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America captured a major share in the global market of Spectral Computed Tomography (CT) Market due to an expansion in the aging population and huge adoption rate of innovative technologies followed by Western and Eastern Europe. The Asia Pacific is also anticipated to have a gradual rise in growth due to improving economies and average expenditure on healthcare.

Key Players

• The "Global Spectral Computed Tomography (CT) Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Fisher Scientific, Agilent Technologies, Koninklijke Philips, Neusoft Medical Systems, General Electric, Pall, Hitachi medical, Xoran Technologies, Varian Medical Systems, Trivitron Healthcare, Siemens Healthcare Private, PerkinElmer, Bio-Rad Laboratories, Cleaver Scientific, NeuroLogica.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Partnerships, Collaborations, and Agreements
• In July 2021, Canon Medical Systems USA announced a collaboration with Cleerly, a healthcare company, to combine Canon's AI-powered CT technology with Cleerly's online pathway solution for the evaluation of coronary artery disease.
• Mergers and Acquisitions
• In April 2021, FUJIFILM Corporation completed its acquisition of Hitachi Diagnostic Imaging-related business. The acquisition is anticipated to boost FUJIFILM's growth in the Medical System Business.
• In November 2020, GE Healthcare has announced that it has acquired Prismatic Sensor AB, a Swedish company that creates photon-counting detectors. This acquisition aid the economic growth of photon-counting CT technology.
• Product Launches and Product Expansions
• In February 2020, GE Healthcare announced the development of its advanced imaging activities in Israel. Moreover, the Israel Innovation Authority offered USD 13.4 plans to upgrade its Rehovot center.
• In April 2020, Canon Medical Systems Corporation has presented a deployable computed tomography solution for scanning patients suffering from viral infectious diseases.